Immunomodulators Market, Global Outlook and Forecast 2022-2028

March 2022 | 74 pages | ID: IA4B8EEDB434EN
Market Monitor Global

Abstracts

Immunomodulators are referred to as the medications that are used for the regulation or for normalizing the immune system.

This report contains market size and forecasts of Immunomodulators in global, including the following market information:

Global Immunomodulators Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Immunomodulators Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Immunomodulators companies in 2021 (%)

The global Immunomodulators market was valued at 140580 million in 2021 and is projected to reach US$ 172080 million by 2028, at a CAGR of 2.9% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Immunosuppressant Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Immunomodulators include Roche, Amgen Inc., Abbott, Johnson & Johnson, Novartis AG, Eli Lilly and Company, Bristol-Myers Squibb Company, Merck & Co. Inc. and Biogen. etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Immunomodulators manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Immunomodulators Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Immunomodulators Market Segment Percentages, by Type, 2021 (%)

• Immunosuppressant
• Immunostimulants

Global Immunomodulators Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Immunomodulators Market Segment Percentages, by Application, 2021 (%)

• Oncology
• Respiratory
• HIV
• Others

Global Immunomodulators Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Immunomodulators Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Immunomodulators revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Immunomodulators revenues share in global market, 2021 (%)

Key companies Immunomodulators sales in global market, 2017-2022 (Estimated), (K Units)

Key companies Immunomodulators sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Roche
• Amgen Inc.
• Abbott
• Johnson & Johnson
• Novartis AG
• Eli Lilly and Company
• Bristol-Myers Squibb Company
• Merck & Co. Inc.
• Biogen

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Immunomodulators Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Immunomodulators Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL IMMUNOMODULATORS OVERALL MARKET SIZE

2.1 Global Immunomodulators Market Size: 2021 VS 2028
2.2 Global Immunomodulators Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Immunomodulators Sales: 2017-2028

3 COMPANY LANDSCAPE

3.1 Top Immunomodulators Players in Global Market
3.2 Top Global Immunomodulators Companies Ranked by Revenue
3.3 Global Immunomodulators Revenue by Companies
3.4 Global Immunomodulators Sales by Companies
3.5 Global Immunomodulators Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Immunomodulators Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Immunomodulators Product Type
3.8 Tier 1, Tier 2 and Tier 3 Immunomodulators Players in Global Market
  3.8.1 List of Global Tier 1 Immunomodulators Companies
  3.8.2 List of Global Tier 2 and Tier 3 Immunomodulators Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Immunomodulators Market Size Markets, 2021 & 2028
  4.1.2 Immunosuppressant
  4.1.3 Immunostimulants
4.2 By Type - Global Immunomodulators Revenue & Forecasts
  4.2.1 By Type - Global Immunomodulators Revenue, 2017-2022
  4.2.2 By Type - Global Immunomodulators Revenue, 2023-2028
  4.2.3 By Type - Global Immunomodulators Revenue Market Share, 2017-2028
4.3 By Type - Global Immunomodulators Sales & Forecasts
  4.3.1 By Type - Global Immunomodulators Sales, 2017-2022
  4.3.2 By Type - Global Immunomodulators Sales, 2023-2028
  4.3.3 By Type - Global Immunomodulators Sales Market Share, 2017-2028
4.4 By Type - Global Immunomodulators Price (Manufacturers Selling Prices), 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Immunomodulators Market Size, 2021 & 2028
  5.1.2 Oncology
  5.1.3 Respiratory
  5.1.4 HIV
  5.1.5 Others
5.2 By Application - Global Immunomodulators Revenue & Forecasts
  5.2.1 By Application - Global Immunomodulators Revenue, 2017-2022
  5.2.2 By Application - Global Immunomodulators Revenue, 2023-2028
  5.2.3 By Application - Global Immunomodulators Revenue Market Share, 2017-2028
5.3 By Application - Global Immunomodulators Sales & Forecasts
  5.3.1 By Application - Global Immunomodulators Sales, 2017-2022
  5.3.2 By Application - Global Immunomodulators Sales, 2023-2028
  5.3.3 By Application - Global Immunomodulators Sales Market Share, 2017-2028
5.4 By Application - Global Immunomodulators Price (Manufacturers Selling Prices), 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Immunomodulators Market Size, 2021 & 2028
6.2 By Region - Global Immunomodulators Revenue & Forecasts
  6.2.1 By Region - Global Immunomodulators Revenue, 2017-2022
  6.2.2 By Region - Global Immunomodulators Revenue, 2023-2028
  6.2.3 By Region - Global Immunomodulators Revenue Market Share, 2017-2028
6.3 By Region - Global Immunomodulators Sales & Forecasts
  6.3.1 By Region - Global Immunomodulators Sales, 2017-2022
  6.3.2 By Region - Global Immunomodulators Sales, 2023-2028
  6.3.3 By Region - Global Immunomodulators Sales Market Share, 2017-2028
6.4 North America
  6.4.1 By Country - North America Immunomodulators Revenue, 2017-2028
  6.4.2 By Country - North America Immunomodulators Sales, 2017-2028
  6.4.3 US Immunomodulators Market Size, 2017-2028
  6.4.4 Canada Immunomodulators Market Size, 2017-2028
  6.4.5 Mexico Immunomodulators Market Size, 2017-2028
6.5 Europe
  6.5.1 By Country - Europe Immunomodulators Revenue, 2017-2028
  6.5.2 By Country - Europe Immunomodulators Sales, 2017-2028
  6.5.3 Germany Immunomodulators Market Size, 2017-2028
  6.5.4 France Immunomodulators Market Size, 2017-2028
  6.5.5 U.K. Immunomodulators Market Size, 2017-2028
  6.5.6 Italy Immunomodulators Market Size, 2017-2028
  6.5.7 Russia Immunomodulators Market Size, 2017-2028
  6.5.8 Nordic Countries Immunomodulators Market Size, 2017-2028
  6.5.9 Benelux Immunomodulators Market Size, 2017-2028
6.6 Asia
  6.6.1 By Region - Asia Immunomodulators Revenue, 2017-2028
  6.6.2 By Region - Asia Immunomodulators Sales, 2017-2028
  6.6.3 China Immunomodulators Market Size, 2017-2028
  6.6.4 Japan Immunomodulators Market Size, 2017-2028
  6.6.5 South Korea Immunomodulators Market Size, 2017-2028
  6.6.6 Southeast Asia Immunomodulators Market Size, 2017-2028
  6.6.7 India Immunomodulators Market Size, 2017-2028
6.7 South America
  6.7.1 By Country - South America Immunomodulators Revenue, 2017-2028
  6.7.2 By Country - South America Immunomodulators Sales, 2017-2028
  6.7.3 Brazil Immunomodulators Market Size, 2017-2028
  6.7.4 Argentina Immunomodulators Market Size, 2017-2028
6.8 Middle East & Africa
  6.8.1 By Country - Middle East & Africa Immunomodulators Revenue, 2017-2028
  6.8.2 By Country - Middle East & Africa Immunomodulators Sales, 2017-2028
  6.8.3 Turkey Immunomodulators Market Size, 2017-2028
  6.8.4 Israel Immunomodulators Market Size, 2017-2028
  6.8.5 Saudi Arabia Immunomodulators Market Size, 2017-2028
  6.8.6 UAE Immunomodulators Market Size, 2017-2028

7 MANUFACTURERS & BRANDS PROFILES

7.1 Roche
  7.1.1 Roche Corporate Summary
  7.1.2 Roche Business Overview
  7.1.3 Roche Immunomodulators Major Product Offerings
  7.1.4 Roche Immunomodulators Sales and Revenue in Global (2017-2022)
  7.1.5 Roche Key News
7.2 Amgen Inc.
  7.2.1 Amgen Inc. Corporate Summary
  7.2.2 Amgen Inc. Business Overview
  7.2.3 Amgen Inc. Immunomodulators Major Product Offerings
  7.2.4 Amgen Inc. Immunomodulators Sales and Revenue in Global (2017-2022)
  7.2.5 Amgen Inc. Key News
7.3 Abbott
  7.3.1 Abbott Corporate Summary
  7.3.2 Abbott Business Overview
  7.3.3 Abbott Immunomodulators Major Product Offerings
  7.3.4 Abbott Immunomodulators Sales and Revenue in Global (2017-2022)
  7.3.5 Abbott Key News
7.4 Johnson & Johnson
  7.4.1 Johnson & Johnson Corporate Summary
  7.4.2 Johnson & Johnson Business Overview
  7.4.3 Johnson & Johnson Immunomodulators Major Product Offerings
  7.4.4 Johnson & Johnson Immunomodulators Sales and Revenue in Global (2017-2022)
  7.4.5 Johnson & Johnson Key News
7.5 Novartis AG
  7.5.1 Novartis AG Corporate Summary
  7.5.2 Novartis AG Business Overview
  7.5.3 Novartis AG Immunomodulators Major Product Offerings
  7.5.4 Novartis AG Immunomodulators Sales and Revenue in Global (2017-2022)
  7.5.5 Novartis AG Key News
7.6 Eli Lilly and Company
  7.6.1 Eli Lilly and Company Corporate Summary
  7.6.2 Eli Lilly and Company Business Overview
  7.6.3 Eli Lilly and Company Immunomodulators Major Product Offerings
  7.6.4 Eli Lilly and Company Immunomodulators Sales and Revenue in Global (2017-2022)
  7.6.5 Eli Lilly and Company Key News
7.7 Bristol-Myers Squibb Company
  7.7.1 Bristol-Myers Squibb Company Corporate Summary
  7.7.2 Bristol-Myers Squibb Company Business Overview
  7.7.3 Bristol-Myers Squibb Company Immunomodulators Major Product Offerings
  7.7.4 Bristol-Myers Squibb Company Immunomodulators Sales and Revenue in Global (2017-2022)
  7.7.5 Bristol-Myers Squibb Company Key News
7.8 Merck & Co. Inc.
  7.8.1 Merck & Co. Inc. Corporate Summary
  7.8.2 Merck & Co. Inc. Business Overview
  7.8.3 Merck & Co. Inc. Immunomodulators Major Product Offerings
  7.8.4 Merck & Co. Inc. Immunomodulators Sales and Revenue in Global (2017-2022)
  7.8.5 Merck & Co. Inc. Key News
7.9 Biogen
  7.9.1 Biogen Corporate Summary
  7.9.2 Biogen Business Overview
  7.9.3 Biogen Immunomodulators Major Product Offerings
  7.9.4 Biogen Immunomodulators Sales and Revenue in Global (2017-2022)
  7.9.5 Biogen Key News

8 GLOBAL IMMUNOMODULATORS PRODUCTION CAPACITY, ANALYSIS

8.1 Global Immunomodulators Production Capacity, 2017-2028
8.2 Immunomodulators Production Capacity of Key Manufacturers in Global Market
8.3 Global Immunomodulators Production by Region

9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints

10 IMMUNOMODULATORS SUPPLY CHAIN ANALYSIS

10.1 Immunomodulators Industry Value Chain
10.2 Immunomodulators Upstream Market
10.3 Immunomodulators Downstream and Clients
10.4 Marketing Channels Analysis
  10.4.1 Marketing Channels
  10.4.2 Immunomodulators Distributors and Sales Agents in Global

11 CONCLUSION

12 APPENDIX

12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Key Players of Immunomodulators in Global Market
Table 2. Top Immunomodulators Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Immunomodulators Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Immunomodulators Revenue Share by Companies, 2017-2022
Table 5. Global Immunomodulators Sales by Companies, (K Units), 2017-2022
Table 6. Global Immunomodulators Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Immunomodulators Price (2017-2022) & (USD/Unit)
Table 8. Global Manufacturers Immunomodulators Product Type
Table 9. List of Global Tier 1 Immunomodulators Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Immunomodulators Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Immunomodulators Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Immunomodulators Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Immunomodulators Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Immunomodulators Sales (K Units), 2017-2022
Table 15. By Type - Global Immunomodulators Sales (K Units), 2023-2028
Table 16. By Application – Global Immunomodulators Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Immunomodulators Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Immunomodulators Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Immunomodulators Sales (K Units), 2017-2022
Table 20. By Application - Global Immunomodulators Sales (K Units), 2023-2028
Table 21. By Region – Global Immunomodulators Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Immunomodulators Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Immunomodulators Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Immunomodulators Sales (K Units), 2017-2022
Table 25. By Region - Global Immunomodulators Sales (K Units), 2023-2028
Table 26. By Country - North America Immunomodulators Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Immunomodulators Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Immunomodulators Sales, (K Units), 2017-2022
Table 29. By Country - North America Immunomodulators Sales, (K Units), 2023-2028
Table 30. By Country - Europe Immunomodulators Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Immunomodulators Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Immunomodulators Sales, (K Units), 2017-2022
Table 33. By Country - Europe Immunomodulators Sales, (K Units), 2023-2028
Table 34. By Region - Asia Immunomodulators Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Immunomodulators Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Immunomodulators Sales, (K Units), 2017-2022
Table 37. By Region - Asia Immunomodulators Sales, (K Units), 2023-2028
Table 38. By Country - South America Immunomodulators Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Immunomodulators Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Immunomodulators Sales, (K Units), 2017-2022
Table 41. By Country - South America Immunomodulators Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Immunomodulators Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Immunomodulators Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Immunomodulators Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Immunomodulators Sales, (K Units), 2023-2028
Table 46. Roche Corporate Summary
Table 47. Roche Immunomodulators Product Offerings
Table 48. Roche Immunomodulators Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 49. Amgen Inc. Corporate Summary
Table 50. Amgen Inc. Immunomodulators Product Offerings
Table 51. Amgen Inc. Immunomodulators Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 52. Abbott Corporate Summary
Table 53. Abbott Immunomodulators Product Offerings
Table 54. Abbott Immunomodulators Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 55. Johnson & Johnson Corporate Summary
Table 56. Johnson & Johnson Immunomodulators Product Offerings
Table 57. Johnson & Johnson Immunomodulators Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 58. Novartis AG Corporate Summary
Table 59. Novartis AG Immunomodulators Product Offerings
Table 60. Novartis AG Immunomodulators Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 61. Eli Lilly and Company Corporate Summary
Table 62. Eli Lilly and Company Immunomodulators Product Offerings
Table 63. Eli Lilly and Company Immunomodulators Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 64. Bristol-Myers Squibb Company Corporate Summary
Table 65. Bristol-Myers Squibb Company Immunomodulators Product Offerings
Table 66. Bristol-Myers Squibb Company Immunomodulators Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 67. Merck & Co. Inc. Corporate Summary
Table 68. Merck & Co. Inc. Immunomodulators Product Offerings
Table 69. Merck & Co. Inc. Immunomodulators Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 70. Biogen Corporate Summary
Table 71. Biogen Immunomodulators Product Offerings
Table 72. Biogen Immunomodulators Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 73. Immunomodulators Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 74. Global Immunomodulators Capacity Market Share of Key Manufacturers, 2020-2022
Table 75. Global Immunomodulators Production by Region, 2017-2022 (K Units)
Table 76. Global Immunomodulators Production by Region, 2023-2028 (K Units)
Table 77. Immunomodulators Market Opportunities & Trends in Global Market
Table 78. Immunomodulators Market Drivers in Global Market
Table 79. Immunomodulators Market Restraints in Global Market
Table 80. Immunomodulators Raw Materials
Table 81. Immunomodulators Raw Materials Suppliers in Global Market
Table 82. Typical Immunomodulators Downstream
Table 83. Immunomodulators Downstream Clients in Global Market
Table 84. Immunomodulators Distributors and Sales Agents in Global Market

List Of Figures

LIST OF FIGURES

Figure 1. Immunomodulators Segment by Type
Figure 2. Immunomodulators Segment by Application
Figure 3. Global Immunomodulators Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Immunomodulators Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Immunomodulators Revenue, 2017-2028 (US$, Mn)
Figure 7. Immunomodulators Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Immunomodulators Revenue in 2021
Figure 9. By Type - Global Immunomodulators Sales Market Share, 2017-2028
Figure 10. By Type - Global Immunomodulators Revenue Market Share, 2017-2028
Figure 11. By Type - Global Immunomodulators Price (USD/Unit), 2017-2028
Figure 12. By Application - Global Immunomodulators Sales Market Share, 2017-2028
Figure 13. By Application - Global Immunomodulators Revenue Market Share, 2017-2028
Figure 14. By Application - Global Immunomodulators Price (USD/Unit), 2017-2028
Figure 15. By Region - Global Immunomodulators Sales Market Share, 2017-2028
Figure 16. By Region - Global Immunomodulators Revenue Market Share, 2017-2028
Figure 17. By Country - North America Immunomodulators Revenue Market Share, 2017-2028
Figure 18. By Country - North America Immunomodulators Sales Market Share, 2017-2028
Figure 19. US Immunomodulators Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Immunomodulators Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Immunomodulators Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Immunomodulators Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Immunomodulators Sales Market Share, 2017-2028
Figure 24. Germany Immunomodulators Revenue, (US$, Mn), 2017-2028
Figure 25. France Immunomodulators Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Immunomodulators Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Immunomodulators Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Immunomodulators Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Immunomodulators Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Immunomodulators Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Immunomodulators Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Immunomodulators Sales Market Share, 2017-2028
Figure 33. China Immunomodulators Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Immunomodulators Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Immunomodulators Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Immunomodulators Revenue, (US$, Mn), 2017-2028
Figure 37. India Immunomodulators Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Immunomodulators Revenue Market Share, 2017-2028
Figure 39. By Country - South America Immunomodulators Sales Market Share, 2017-2028
Figure 40. Brazil Immunomodulators Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Immunomodulators Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Immunomodulators Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Immunomodulators Sales Market Share, 2017-2028
Figure 44. Turkey Immunomodulators Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Immunomodulators Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Immunomodulators Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Immunomodulators Revenue, (US$, Mn), 2017-2028
Figure 48. Global Immunomodulators Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Immunomodulators by Region, 2021 VS 2028
Figure 50. Immunomodulators Industry Value Chain
Figure 51. Marketing Channels